Torben Lund-Hansen
CIK 1753134 · SVP & CHIEF TECHNICAL OFFICER · last filed 2024-08-30
Torben Lund-Hansen is a SVP & CHIEF TECHNICAL OFFICER who has filed 9 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for YMAB, was dated Aug 30, 2024. Across all open-market trades the lifetime net is −$768.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
-$768.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | SVP & CHIEF TECHNICAL OFFICER | 131,262 | $8.61 | $1.13M | -$768.5K | 9 | 2024-08-30 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-30 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | — | -$549.5K | EDGAR |
| 2024-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +17,800 | $0 | EDGAR |
| 2023-01-30 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +17,800 | $0 | EDGAR |
| 2022-04-28 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-16 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-13 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |